We describe procedures for determining cytosine and oroticacid in urine.We determine cytosine by cationexchange analysis with either HCI or a pH 5.2 bufferas eluent. Oroticacid isfirst separatedby an anion-exchange separativeprocedure;afterlyophilization, the product is subjected to "high-pressure"liquid Chromatography for further separation and detection. We analyzed urine from normal subjectsand from immunodeficientchildren. Three children with severe combined immunodeficiency had increased levels of cytosine in the urine (23-160 mmol/ mol creatinine); one childwith severe combined immunodeficiency and two children with other immunodeficiencies had normal urinary levels (<2 mmol/mol creatinine). Orotic acid excretion in urine was normal (1-5 mmol/mol creatinine) inallof the immunodeficient children. We discuss the possible significance of the increased cytosine excretion in the three children with severe combined immunodeficiency.
exchange analysis with either HCI or a pH 5.2 bufferas eluent. Oroticacid isfirst separatedby an anion-exchange separativeprocedure;afterlyophilization, the product is subjected to "high-pressure"liquid Chromatography for further separation and detection. We analyzed urine from normal subjectsand from immunodeficientchildren. Three children with severe combined immunodeficiency had increased levels of cytosine in the urine (23-160 mmol/ mol creatinine); one childwith severe combined immunodeficiency and two children with other immunodeficiencies had normal urinary levels (<2 mmol/mol creatinine). Orotic acid excretion in urine was normal (1) (2) (3) (4) (5) mmol/mol creatinine) inallof the immunodeficient children. We discuss the possible significance of the increased cytosine excretion in the three children with severe combined immunodeficiency.
AddItIonal Keyphrases:
"high-pressure" liquid chromatography #{149}genetic disorders metabolism of purines and pyrimidines Although the cause of most cases of primary immunodeficiency is still unknown, two genetic disorders of purine metabolism have been identified in children with immunodeficiency diseases. A deficiency of adenosine deaminaset (ADA; adenosine aminohydrolase, EC 3.5.4.4) is associated with severe combined immunodeficiency, whereas a deficiency of purine-nucleoside phosphorylase (PNP; purine-nucleoside: orthophosphate ribosyltransferase, EC 2.4.2.1) is associated with a deficiency in T lymphocyte number and function. These two enzymes have a role in purine catabolism, in the salvage pathway for purines, and in the re-utilization of the purine moiety of adenosylmethionine (1) (2) (3) . The modifications in metabolism of purines and purine nucleosides in these two genetic disorders have been studied previously (2) (3) (4) (5) (6) . Various workers have also suggested that secondary alterations in pyrimidine metabolism may be involved in the failure of ADA-and PNP-deficient lymphocytes to proliferate in vitro when stimulated with mitogens (7, 8) . Also, Cohen et al. (9) have reported that children with PNP deficiency excrete increased amounts of orotic acid, an intermediate in the pyrimidine biosynthetic pathway. These workers suggested that an increase in orotic acid excretion might be a common feature of immunodeficient children. In this study, we present data on urinary excretion of two pyrimidines, cytosine and orotic acid (Figure 1 ), in six children with various immunodeficiency diseases. We have used cation-exchange techniques for the separation and determination of cytosine, and have developed a sensitive procedure in which an anion-exchange separation is followed by "high-pressure" liquid chromatography (HPLC) for determining orotic acid. and acetic acid. Since the cation was the eluting ion, listed sodium acetate buffer concentrations refer to Na+ concentration.
Materials and Methods

Reagents
All components of buffers were reagent grade, and their pH values refer to pH at 22 #{176}C. The HCI (1.5 mol/L) and formic acid (0.50 and 4.0 mol/L) solutions were prepared by dilutingconcentrated solutions(reagentgrade) and titrated with standardized NaOH to ensure the correct concentrations. 
Analytical Methods and Instruments
Patients
Information regarding the immunodeficient children of this study is summarized in Table 1 . Another female subject, contaminant (probably acetylsulfamethoxazole) in the lyophilized orotic acid fractions from case SMF, and used the following procedure to remove it. We dissolved in water the lyophilized material from the anion-exchange column and spotted a portion along a 6-cm line at the base of a rectangular piece (19 x 21 cm) of Whatman No. 1 filter paper. We spotted along an adjacent line a sample containing an orotic acid standard.
We stapled the paper into a cylinder and developed it with 95% ethanol/water (4/1) as solvent. Orotic acid migrated with an R of 0.38 and the drug metabolite with an Rf of 0.81. For the unknown, we cut a 1.7 X 6.5-cm strip, corresponding to the R1 of orotic acid, from the filter paper, eluted it with water, and subjected the orotic acid-containing sample to HPLC for flnal separation and analysis. Recovery of orotic acidfrom the paper forthe sample with added oroticacidwas 92%.
Results
Cation-exchange Separations of Urinary Components and of Known Compounds
Elution profiles of urinary components separated by cation-exchange analysis are shown in Figure 2 (HC1 elution) and children with severe illness, we collected random urine specimens in most cases. Therefore, values for cytosine and orotic acid are expressed in relation to either creatinine or uric acid excretion. In some instances, cytosine excretion is also compared to that of pseudouridine, the primary pyrimidinecontaining compound excreted in human urine.
Excretion Values
Cytosine.
Values for urinary excretion of cytosine in the immunodeficient children are summarized in Table 2 . Of three children with severe combined immunodeficiency and normal
ADA
and PNP activities, two showed increased excretion levels for cytosine.
In one of these, JRG, excretion was very high in three separate urine samples. Cytosine excretion in this child was 73% of that of pseudouridine.
A second child, SMF, also showed cytosine excretion values much above normal, although the excretion was much lower than that for JRG. The third child with severe combined immunodeficiency, DVC, had normal cytosine excretion values, as did two children with milder immune deficiencies (JLL and JRK). One child, yAW, who was recovering from pneumonia, also excreted cytosine at a level very significantly above that found for other normal subjects. We have not had an opportunity to repeat the studies on this child. The child with severe combined immunodeficiency and ADA deficiency, LLA, did not excrete cytosine for the first 16 months of life, but subsequently has excreted cytosine in every urine specimen tested over a period of 26 months. In five 24-h urine specimens collected during the latter period, his cytosine excretion was 5.00 ± 2.24 zmol/24 h per kg body weight.
Orotic acid. The excretion of orotic acid for each of our immunodeficient children (Table 3) Normal children (n = 2) Orotic aciduria
a Listed values represent the mean of triplicate HPLC analyses.
b Urine collection before beginning erythrocyte infusions as therapy.
C 5ee text for details.
Discussion
Separative Procedures for Cytosine
The procedures we used to separate cytosine depend primarily upon the properties of the amino and enolic groups on the pyrimidine ring. The pK values of these groups are:
amino, 4.6, and enolic, 12.2 (13). Consequently, cytosine is cationic in acid solutions, but will have no charged groups in the 5.6 to 10 pH range. The preliminary separation on the short anion-exchange column at pH 10 has been particularly useful in separating cytosine from a number of other related compounds of urine. Guanine, hypoxanthine, xanthine, and their nucleosides have a negative charge at pH 10 and are retained on the anion-exchange column, whereas cytosine passes through into the column wash.
We identified cytosine in our procedure by comparing the following properties of the isolated compound with those of known cytosine: (a) elution positions from cation-exchange columns with either HCI or acetate buffer as eluents ( Figures  2 and 3) ; (b) ultraviolet absorption spectra in HC1 (pH 1), in buffer (pH 7), and in NaOH (pH 14); and (c) excitation and fluorescence spectra of the etheno derivative. The absorption maximum for cytosine changes with pH as follows: acid (pH 1), 276 nm; neutral (pH 7), 267 nm; and basic (pH 14), 282 nm.
The absorption spectrum of the isolated cytosine at pH 14 was useful in distinguishing cytosine from cytidine or deoxycytidine. Cytosine nucleosides do not have a 2-enolic group, nor do they show the spectral shift to higher wavelengths in basic Separative Procedures for Orotic Acid standard curve. We have also analyzed all samples by measuring absorbance of HPLC profiles at 254 nm, to minimize the possibility that we were detecting a compound other than orotic acid. In a few cases, there may have been some minor contaminants in the orotic acid peak. The lower limit for detection of orotic acid by this procedure is about 1 cmol/L of urine. As concentrations approach this limit, positive identification of orotic acid becomes more uncertain.
In two cases, orotic acid was added to urine at a concentration of 114 cmol/L, and carried through the entire separative procedure. Orotic acid recovery in each case was 110%.
Possible Sources of Urinary Cytosine
Diet. The following considerations make it unlikely that diet was the source of the urinary cytosine.
First, JRG, the child with severe combined immunodeficiency who excreted the largestamounts of cytosine (Table 2) , received a diet containing only minimal amounts of nucleic acids. He also excreted consistently large amounts of cytosine on each of three occasions over a period of six weeks when we studied his urine. The ADA-deficient child, LLA, began excreting cytosineat about 16 months of age and has excreted iton every occasion since (26 months). There was no recognizable change in hisdiet before initiation of cytosine excretion. Also, on three occasions, 24-h urines from LLA have been collected in 8-h portions, and there has been no consistent variation of cytosine excretion with the time of day or in relation to meals. Moreover, the beginning of cytosine excretion by LLA did not correspond to the beginning of erythrocyte infusions used as therapy.
Medications. All medications were discontinued for JRG for several days before one of the urine collections; the cytosine excretion, nevertheless, remained high. After cytosine excretion began at age 16 months, the ADA-deficient child, LLA, has been on a varying regimen of drugs for the subsequent 26 months; although there have been quantitative differences in the amount excreted, cytosine has been in each of 16 urine samples in amounts well above normal levels. The possibility remains that either the drugs or the lack of immune response may have contributed to an alteration of gastrointestinal tract microorganisms, which in turn contributed to the urinary cytosine.
It is also possible that minor systemic infections might cause alterations in turnover of cellular nucleic acids.
Metabolism.
Although cytidine or deoxycytidine would seem to be the most likely immediate metabolic precursors, enzymes cleaving these nucleosides to form cytosine have not been found in mammalian tissues ( Figure 5 ). The finding of cytosine in the urine of our subjects suggests the need for a more careful search for a cytidine glycohydrolase or phosphorylase in mammals. Once formed in tissues, cytosine would appear to be an end-product of metabolism, since no enzymes are known in mammals that will convert cytosine to either nucleosides or nucleotides (16, 17) . Although cytosine deaminase has been found in microorganisms, it has not been found in mammals, so cytosine would not be converted to uracil. In the normal pathway for catabolism of cytosine flucleotides ( Figure 5 ) pyrimidine-5'-nucleotidase (reaction 6) acts to form cytidineor deoxycytidine.These nucleosidesare deaminated by cytidine deaminase to form uridine and deoxyuridine, respectively. These two uracil nucleosides are converted to uracil by uridine phosphorylase. The uracil is then degraded, ultimately going via fl-alanine to C02, NH3, and H20. One possible source of deoxycytidine for cytosine formation would be cellular DNA. If the cytosine of the DNA is not adequately methylated in the 5-position because of defective methylation (1, 2) , the DNA may be susceptible to the action of endonucleases.
These could be repair endonucleases (18) or restriction endonucleases (19) . An increased turnover of cytosine nucleotides in DNA could provide a source of the urinary cytosine that we have found.
In evaluating pyrimidine metabolism, it is important to note where interconversions between pathways may occur ( Figure  5 ). As noted above, cytosine-to-uracil interconversions occur only at the nucleoside level. Conversion of uracil to cytosine occurs only at the level of the nucleoside triphosphate, and conversion of the ribose moiety of these nucleotides to deoxyribose occurs only with cytidine diphosphate. 
Other Enzymatic Deficiencies of Pyrimidine Metabolism
Orotic aciduria.
We have also studied cytosine excretion in a youth (age 16 years, subject JP, ref. 22) with orotic aciduria, a genetic disorder involving the pyrimidine biosynthetic pathway. This subject, who weighed 52 kg, excreted over 1 g of orotic acid per day. Although he received 2 g of uridine per day as therapy, his urinary cytosine excretion was in the normal range. This finding would be consistent with the view that cytosine is an end-product of pyrimidine catabolism rather than being associated with the biosynthetic pathway.
The lack of urinary cytosine in this youth also supports the accepted view that conversion of uracil to cytosine occurs at the nucleotide level and not at the level of nucleosides.
Orotic Acid Excretion in lmmunodeficiencies
Cohen et al. (9) , in their studies of children with PNP deficiency, noted an increased urinary excretion of orotic acid, with levels in this genetic disorder of about 60 mol/L compared with normal values of less than 5 tmolfL.
Edwards et al. (6) could not detect orotic acid in the urine of two children with PNP deficiency, but their assay procedure would probably not be sensitive enough to detect the levels reported by Cohen and coworkers. The finding of increased urinary orotic acid suggested the possibility to Cohen et al. of a secondary block in these children in the pyrimidine biosynthetic pathway. The primary metabolic block in PNP deficiency is in the conversion of inosine and guanosine to hypoxanthine and guanine, which causes a markedly increased urinary excretion of inosine, guanosine, and their deoxy analogs. As shown in Figure 5 Green and Chan (7) had previously postulated that pyrimidine biosynthesis was impaired when ADA was either deficient or inhibited.
The preliminary anion-exchange separation followed by HPLC provided the required sensitivity and specificity for determination of orotic acid in urine of our immunodeficient patients.
The data in Table 2 show that orotic acid excretion is not increased in our ADA-deficient child (LLA) or in the three other children with severe combined immunodeficiency, or in the two other children with milder immune deficiencies. We have not had the opportunity to study a patient with PNP deficiency. However, our studies demonstrate that an in-creased excretion of orotic acid is not a general finding in immune deficiency disorders.
